Starling Oncology (STLN) Stock Analysis

What Starling Oncology does

Starling Oncology, Inc., formerly The Oncology Institute, is a value-based oncology company advancing cancer care in the community setting. Founded in 2007, the company offers cutting-edge, evidence-based cancer treatments, including clinical trials and transfusions, to a large patient population. It operates as an integrated oncology platform serving patients, providers, and health plans across multiple markets with a focus on delivering high-quality, patient-centered care.

Key metrics

ETFs linked to STLN

Broad-market and Healthcare sector ETFs an investor holding Starling Oncology is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how STLN fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Starling Oncology?

Starling Oncology trades under the ticker STLN on NASDAQ.

Which exchange is STLN listed on?

STLN is listed on NASDAQ.

What sector does Starling Oncology operate in?

Starling Oncology is classified in the Healthcare sector (Medical - Care Facilities industry).

How can PortView help analyze STLN in a portfolio?

PortView shows STLN's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.